Jinhai International Expands with Strategic Investment

Jinhai International Group Holdings Limited (HK:2225) has released an update.

Jinhai International Group Holdings Limited, through its subsidiary Jinhai SH, has entered into a Cooperation Framework Agreement to invest up to RMB 16,500,000 in Shanghai Lichen, a medical equipment company. This strategic investment, funded by internal resources, aims to integrate Shanghai Lichen’s operations with Jinhai’s medical products and services, potentially resulting in Shanghai Lichen becoming a subsidiary of the group. Additionally, the agreement includes a change of Shanghai Lichen’s name to Shanghai Jinhai Lichen Medical Technology Co., Ltd., reflecting the new partnership.

For further insights into HK:2225 stock, check out TipRanks’ Stock Analysis page.